-+ 0.00%
-+ 0.00%
-+ 0.00%

CR Pharmaceutical Holdings, China Resources Pharmaceutical unit, posts 1H net profit RMB 5.18 billion

PUBT·08/31/2026 10:05:14
Listen to the news
CR Pharmaceutical Holdings, China Resources Pharmaceutical unit, posts 1H net profit RMB 5.18 billion
  • China Resources Pharmaceutical Holdings, a wholly owned subsidiary of China Resources Pharmaceutical Group, reported unaudited results for the six months ended June 30, 2026.
  • Operating revenue rose to RMB 135.35 billion from RMB 132.79 billion.
  • Net profit slipped to RMB 5.18 billion from RMB 5.24 billion.
  • Total assets increased to RMB 294.45 billion from RMB 286.3 billion; total liabilities climbed to RMB 180.44 billion from RMB 172.08 billion.
  • Net cash from operating activities eased to RMB 1.45 billion from RMB 1.57 billion; cash and cash equivalents ended at RMB 15.54 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12308624), on August 31, 2026, and is solely responsible for the information contained therein.